Abstract
The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Current Pharmaceutical Design
Title:Dietary Intervention for Allergic Disease
Volume: 20 Issue: 6
Author(s): Yi Huang, Guansong Wang and Changzheng Wang
Affiliation:
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Abstract: The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Export Options
About this article
Cite this article as:
Huang Yi, Wang Guansong and Wang Changzheng, Dietary Intervention for Allergic Disease, Current Pharmaceutical Design 2014; 20 (6) . https://dx.doi.org/10.2174/13816128113199990049
DOI https://dx.doi.org/10.2174/13816128113199990049 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomarkers in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
Current Vascular Pharmacology Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Major Drug Metabolizing CYPs by Common Herbal Medicines used by HIV/AIDS Patients in Africa– Implications for Herb- Drug Interactions
Drug Metabolism Letters The Impact of Metabolic Disease Associated with Metabolic Syndrome on Human Pregnancy
Current Pharmaceutical Biotechnology Fibrinolytic Actinokinase-A Short Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Training Pediatric Residents for Intervention on Tobacco
Current Pediatric Reviews Hypertension in Older Patients
Current Hypertension Reviews Balancing the Risks of Thrombosis and Bleeding Following Transcatheter Aortic Valve Implantation: Current State-of-Evidence
Current Pharmaceutical Design Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Current Medicinal Chemistry Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Foreword
Current Nutrition & Food Science Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects
Current Drug Metabolism Nutrigenomics and Personalized Diet: What are the Anticipated Impacts for Research on Chronic Diseases and Public Health?
Current Pharmacogenomics and Personalized Medicine A More Radical Solution
Reviews on Recent Clinical Trials Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pentraxins: CRP and PTX3 and Cardiovascular Disease
Inflammation & Allergy - Drug Targets (Discontinued)